15 weight loss telehealth providers serve Connecticut in 2026. Compare Ro, Medvi, Wegovy access, compounded semaglutide pricing, and CT insurance coverage rules.
Which Weight Loss Providers Are Actually Available in Connecticut
Fifteen
weight loss telehealth providers serve Connecticut residents in 2026. That is a strong number compared to many states, and it gives you real options across price points, medication types, and care models. Before you spend time evaluating a platform, though, know which ones are off the table: Clinic Secret, Nurx, and UrWay Health do not operate in Connecticut. If you find those mentioned in generic telehealth roundups, you can skip them entirely.
The 15 that do serve Connecticut are Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. That list covers every major treatment path: brand-name
GLP-1s like Wegovy and Ozempic, compounded semaglutide and tirzepatide, older medications like phentermine and metformin, and behavioral coaching programs layered on top of medication. Connecticut residents are not forced into a narrow menu the way residents in some smaller states are.
The right starting point depends heavily on what you actually want. If cost is the primary filter, Medvi is the answer. If you have insurance and want to use it for brand-name Wegovy, Ro and Henry Meds are the names to know. If you are brand new to GLP-1 medications and want hand-holding through the process, MyStart Health is specifically positioned for that. The sections below break each scenario down in detail so you are not guessing.
Connecticut's Insurance Parity Law and What It Means for Your Weight Loss Costs
Connecticut has full telehealth
insurance parity, meaning your insurance company is legally required to reimburse an online weight loss consultation at the same rate as an in-person visit. This is not the case in every state. If you are in Connecticut and have commercial insurance, you should not be paying out-of-pocket for your provider visit when you can find a platform that bills your insurer. That visit cost, which can run $75 to $150 on cash-pay platforms, disappears when you use a parity-compliant service.
PlushCare is the most straightforward insurance-friendly option in Connecticut. It functions like a primary care practice that happens to be online, accepts most major insurance plans, and handles prior authorization paperwork for GLP-1 medications. If your insurer covers Wegovy or Zepbound, PlushCare can manage that process for you. Henry Meds works similarly, with a specific focus on diabetes and metabolic health, and it has direct experience working through Connecticut insurance plans for Ozempic coverage.
Ro is worth mentioning here separately because it goes one step further than most platforms. Ro actively helps you navigate brand-name GLP-1 access, meaning it will work with your insurance on prior auth for Wegovy or Ozempic, and it also has a cash-pay compounded semaglutide path if your insurer says no. That dual-track setup is genuinely useful in Connecticut, where insurer decisions on GLP-1 coverage vary significantly between Anthem, Cigna, Aetna, and the various employer-sponsored plans common in the Hartford and Fairfield County corridors.
Connecticut also has broader Medicaid coverage for preventive women's health care than many states. If you are on HUSKY Health and meet clinical thresholds for weight loss treatment, it is worth a direct call to check your specific plan's formulary before assuming you will need to pay cash for everything.
The Cheapest Way to Get Weight Loss Medication in Connecticut Right Now
If you are paying out of pocket and want to keep costs as low as possible, Medvi is the answer for Connecticut. Compounded semaglutide runs $149 to $199 per month all-inclusive on Medvi, meaning that price covers your medication, provider visit, and ongoing clinical support. There are no separate consultation fees layered on top. For context, brand-name Wegovy without insurance runs over $1,300 per month at Connecticut retail pharmacies. Compounded semaglutide at $149 is the same active ingredient at a fraction of the cost, dispensed through a licensed 503B pharmacy.
Skinny.Rx is a close second for budget-focused Connecticut residents. It offers straightforward monthly pricing on compounded semaglutide with no frills and no long onboarding process. It has fewer reviews than Medvi nationally, but the pricing structure is transparent and the medication path is the same. If Medvi has a waitlist or supply delay, Skinny.Rx is a reasonable fallback.
Sesame Care takes a different approach that can also work out cheap depending on how you use it. It operates as a pay-per-visit marketplace rather than a subscription, so if you only need one or two consultations to get a prescription written and then fill it at a local Connecticut pharmacy yourself, you are not locked into a monthly platform fee. The trade-off is that Sesame does not manage medication supply for you the way Medvi or Ro does, so you need to be more hands-on.
Compounded Semaglutide and Tirzepatide in Connecticut: What's Legal and What to Expect
Compounded GLP-1 medications are available in Connecticut in 2026 through licensed 503B outsourcing facilities, which are FDA-regulated compounding pharmacies that produce medications at scale. This is the legal framework that allows platforms like Medvi, Sprout Health, Shed, and others to ship compounded semaglutide and tirzepatide to Connecticut residents. The key phrase is 503B licensed. If a platform cannot tell you which 503B facility fills their prescriptions, that is a red flag.
The reason compounded versions exist and remain available is that Wegovy and Ozempic have experienced supply constraints, and FDA policy allows compounding to continue as a practical alternative during those periods. For Connecticut residents, this means you can realistically access semaglutide-based weight loss treatment at $149 to $199 per month rather than the brand-name price, and the clinical effect is the same active compound at the same doses.
Compounded tirzepatide is also available in Connecticut. Tirzepatide is the active ingredient in Zepbound and Mounjaro. Sprout Health and Shed both offer tirzepatide-based compounded programs for Connecticut residents. The pricing is typically slightly higher than semaglutide, running $200 to $350 per month depending on dose and platform. If you have already tried semaglutide without adequate results, tirzepatide is a clinically meaningful step up and worth discussing with a provider.
One thing to set expectations on: compounded medications are not interchangeable with brand-name products at your Connecticut pharmacy. You receive them directly through the platform or their affiliated mail pharmacy. You do not take a prescription to CVS or Walgreens and fill compounded semaglutide there. The entire supply chain runs through the telehealth platform and their 503B partner.
Can You Get Phentermine Online in Connecticut?
This is one of the most common searches Connecticut residents run, and the answer is yes, but with conditions. Phentermine is a Schedule IV controlled substance, which means federal regulations require a legitimate prescriber-patient relationship before any controlled substance can be prescribed. In Connecticut, telehealth providers can prescribe phentermine, but they must conduct a thorough clinical evaluation first. You cannot get a phentermine prescription in three clicks on a bare-bones intake form.
Platforms that offer phentermine as part of their Connecticut weight loss programs include PlushCare, Sesame Care, and Peter MD. Peter MD in particular covers weight loss alongside men's health and uses physician-led protocols that include non-GLP-1 options like phentermine and metformin. If you prefer phentermine over injectable medications, or if you are not clinically eligible for GLP-1s, these platforms are the ones to look at.
Metformin and bupropion-naltrexone are also available through Connecticut telehealth providers without the controlled substance restrictions. These are oral medications with different mechanisms from GLP-1 injectables. They produce more modest weight loss results on average, but they are often a better fit if you have contraindications to GLP-1s or want to start with something non-injectable. MyStart Health covers these in addition to GLP-1 options, which is part of why it works well for people newer to weight loss treatment.
The Highest-Rated Weight Loss Platforms Serving Connecticut in 2026
Hims and Strut both carry a 9.0 rating, the highest among all 15 Connecticut providers, though Hims is the more relevant one for pure weight loss since Strut focuses primarily on hair loss and men's health compounding. Hims has a well-built mobile experience, affordable pricing, and a weight loss track that includes compounded semaglutide with ongoing provider check-ins. For Connecticut residents who want a polished digital experience and do not need intensive clinical hand-holding, Hims is a strong pick.
Ro sits at 8.9 alongside Medvi and has over 32,100 verified reviews. Where Ro earns its score is in the breadth of its clinical approach. It does not just write a prescription and disappear. Ro's platform includes ongoing care coordination, insurance navigation for brand-name GLP-1s, and a structured program that monitors your progress. For Connecticut residents who have insurance that might cover Wegovy, Ro is probably the most capable platform at actually getting that coverage sorted out.
Medvi also holds an 8.9 rating and has earned the designation of top choice specifically because of what it delivers for the price in Connecticut. At $149/month all-inclusive with no separate fees, it matches or beats every other platform on cost while maintaining a rating that confirms the clinical quality is real. If you are uninsured or your insurer does not cover GLP-1s, Medvi's price-to-quality ratio is genuinely hard to beat in Connecticut.
Hers is worth calling out specifically for Connecticut women. It holds an 8.8 rating with nearly 30,000 reviews and covers weight loss alongside birth control, hair loss, and
mental health in a single platform. Connecticut's full insurance parity and strong Medicaid access for women's preventive care makes Hers particularly practical here. If you want a single platform that can handle multiple health needs under one login and one potential insurance billing relationship, Hers is built for exactly that.
Getting Wegovy or Ozempic in Connecticut: What the Brand-Name Path Actually Looks Like
Brand-name Wegovy and Ozempic are available in Connecticut, but the access path is genuinely complicated by insurance requirements and prior authorization rules. No telehealth platform can just write you a Wegovy prescription and have it show up at your door without a prior auth from your insurer if you want it covered. The prior auth process requires documentation of your BMI, any
weight-related comorbidities like
type 2 diabetes,
hypertension, or sleep apnea, and often proof that you have tried other interventions first.
The clinical threshold for GLP-1 eligibility in Connecticut follows standard guidelines: a BMI of 30 or higher without comorbidities, or a BMI of 27 or higher with at least one weight-related condition. Most Connecticut residents who are genuinely interested in Wegovy will qualify on the BMI criterion alone, but the insurance approval is a separate question from clinical eligibility.
Ro and Henry Meds are the two Connecticut-available platforms most experienced at managing the insurance side of brand-name GLP-1 access. Henry Meds has a specific focus on metabolic conditions and Ozempic in its original diabetes indication, which sometimes opens a different insurance pathway than Wegovy. If you have type 2 diabetes and your provider is prescribing Ozempic for that indication, your coverage odds improve substantially over a straight Wegovy request for weight loss alone. Ro handles the broader case including non-diabetic patients seeking Wegovy and will pursue the prior auth process on your behalf.
What Makes Weight Loss Telehealth Different in Connecticut vs. Other States
Connecticut is one of the more favorable states for telehealth weight loss treatment, and several specific factors work in your favor. Full insurance parity has been in place long enough that most major insurers operating in Connecticut, including Anthem BlueCross BlueShield of Connecticut, Cigna, and Aetna, have established telehealth billing processes. You are not fighting for coverage on a procedural technicality; the billing infrastructure exists and works.
Connecticut also has a relatively high density of employed residents with employer-sponsored insurance, particularly in Fairfield County and the Hartford metro. That employer coverage often includes GLP-1 benefits that have expanded significantly since 2024 as large employers added weight management coverage to compete for talent. If you have employer insurance, it is worth checking your benefits portal specifically for weight management or GLP-1 coverage before assuming you need to use a cash-pay platform.
The state's proximity to major medical centers like Yale New Haven Hospital and Hartford HealthCare also means Connecticut's telehealth providers are operating in a market where patients are health-literate and providers have to compete on clinical quality, not just price. That competitive pressure tends to keep standards higher. You are less likely to encounter a Connecticut-serving platform that operates as a pure prescription mill compared to states with less regulatory oversight.
One practical consideration specific to Connecticut is that many residents commute to New York for work. If you spend significant time in New York, confirm that any platform you choose is licensed in both states, or that Connecticut-based prescriptions will remain valid for your mail pharmacy deliveries regardless of where you physically are during the week. All 15 platforms listed here are licensed in Connecticut; multi-state coverage varies and is worth confirming if you travel regularly.
Matching the Right Connecticut Provider to Your Specific Situation
If you are uninsured and want the lowest possible monthly cost, start with Medvi at $149/month. No other Connecticut-available platform reliably beats that price for compounded semaglutide with clinical support included. If Medvi's supply is delayed or you want a second option at a similar price tier, Skinny.Rx is the fallback.
If you have insurance and want to use it, begin with PlushCare or Ro. PlushCare works best if you want something that functions like a primary care relationship and handles billing to your Connecticut insurer. Ro is the better choice if your goal is specifically brand-name Wegovy and you want a platform experienced at fighting prior auth denials and walking you through the appeals process when needed.
If you are new to weight loss medication and feel overwhelmed by the options, MyStart Health is specifically designed for that. It carries an 8.6 rating and is positioned around hand-holding and
lifestyle coaching alongside medication, which makes the transition to GLP-1 treatment less clinical and more supported. The all-inclusive pricing removes the anxiety of unexpected costs.
If you want behavioral support layered on top of medication, Shed combines compounded GLP-1 medications with structured behavioral coaching. Sprout Health similarly offers nutritionist support alongside its medication program. Both serve Connecticut and are worth considering if past weight loss attempts failed partly because the clinical piece was solved but the behavioral piece was not addressed.
If you are a Connecticut woman who wants a platform covering multiple health areas, Hers is the obvious choice. Weight loss, birth control, mental health, and hair loss all in one place, billed through a single telehealth relationship that Connecticut's parity law supports. For Connecticut men wanting similar multi-condition coverage, Hims or Peter MD covers ED, hair loss, mental health, and weight loss under one platform.
Frequently Asked Questions
How many weight loss telehealth providers are available in Connecticut in 2026?
Fifteen weight loss telehealth providers serve Connecticut residents in 2026. They are Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. Three platforms that appear in national roundups, Clinic Secret, Nurx, and UrWay Health, do not operate in Connecticut, so skip them if you encounter them. The 15 available providers cover every major treatment path from compounded semaglutide at $149 per month to insurance-navigated brand-name Wegovy to behavioral coaching programs layered on top of medication.
Is Ro available in Connecticut for Wegovy prescriptions?
Yes, Ro is fully available in Connecticut and is one of the stronger options here specifically because of how it handles brand-name GLP-1 access. Ro works with Connecticut insurance plans on prior authorization for Wegovy and Ozempic, which is the main barrier most residents face. If your insurer denies coverage, Ro also offers a compounded semaglutide path so you are not left without medication while appealing. For Connecticut residents with Anthem, Cigna, or Aetna plans that may cover GLP-1s, Ro's dual-track approach, insurance first, compounded as backup, is genuinely practical. Ro holds an 8.9 rating from over 32,100 reviews and is among the most capable platforms at navigating the brand-name access process in Connecticut.
What is the cheapest weight loss medication program available in Connecticut?
Medvi is the lowest-cost option for Connecticut residents paying out of pocket. Compounded semaglutide runs $149 to $199 per month all-inclusive, meaning provider visits and clinical support are included in that price. No separate consultation fees are added on top. Skinny.Rx is a close second with similarly straightforward monthly pricing. For context, brand-name Wegovy at Connecticut retail pharmacies costs over $1,300 per month without insurance. Compounded semaglutide uses the same active ingredient at a fraction of the cost, dispensed through an FDA-regulated 503B pharmacy. Medvi holds an 8.9 rating from over 33,200 verified reviews, confirming the clinical quality matches the low price for Connecticut patients.
Can I get semaglutide through telehealth in Connecticut without insurance?
Yes. Compounded semaglutide is available in Connecticut through multiple telehealth platforms without insurance. Medvi, Skinny.Rx, Shed, Sprout Health, and Hims all offer compounded semaglutide to Connecticut residents on a cash-pay basis. The standard price range is $149 to $299 per month depending on the platform and dose tier. Connecticut's regulatory environment permits compounded GLP-1 prescriptions through licensed 503B pharmacies, which is the legal framework all of these platforms use. You do not need a referral from a primary care provider. You complete an online intake, a licensed Connecticut provider reviews it, and medication ships directly to your Connecticut address if you qualify clinically.
Does Connecticut insurance cover online weight loss visits the same as in-person?
Yes. Connecticut has full telehealth insurance parity, which means your insurer is legally required to reimburse online weight loss consultations at the same rate as in-person visits. This applies to commercial insurance plans regulated in Connecticut. Major Connecticut insurers including Anthem BlueCross BlueShield of Connecticut, Cigna, and Aetna have established telehealth billing processes that support this. Practically, this means if you use PlushCare or Ro and have Connecticut insurance, your provider visit cost may be partially or fully covered by your plan. The medication cost is a separate question governed by your pharmacy benefits, but the visit itself should not be an out-of-pocket expense if your plan covers primary care.
Can I get phentermine prescribed online in Connecticut?
Yes, phentermine can be prescribed through telehealth in Connecticut, but it requires a proper clinical evaluation because it is a Schedule IV controlled substance. You cannot get it through a bare-bones online intake form. Platforms that include phentermine as part of their Connecticut weight loss programs include PlushCare, Sesame Care, and Peter MD. Each requires a thorough review of your medical history, current medications, and weight history before a provider will prescribe a controlled substance. If you are looking for a non-injectable oral alternative to GLP-1 medications, phentermine is a reasonable clinical option for some Connecticut patients, and metformin or bupropion-naltrexone are available with fewer prescribing restrictions through most of the same platforms.
Is compounded tirzepatide available in Connecticut?
Yes, compounded tirzepatide is available in Connecticut through licensed 503B pharmacies that partner with telehealth platforms. Sprout Health and Shed both offer tirzepatide-based programs for Connecticut residents. Tirzepatide is the active ingredient in Zepbound and Mounjaro, and compounded versions are legally available under the same FDA framework that permits compounded semaglutide during brand-name supply constraints. Pricing for compounded tirzepatide runs slightly higher than semaglutide, typically in the $200 to $350 per month range depending on dose and platform. Clinically, tirzepatide targets two hormonal pathways instead of one, which produces meaningfully stronger average weight loss results in trial data. It is a legitimate option for Connecticut patients who have tried semaglutide without sufficient results.
Which Connecticut weight loss telehealth platform is best for women?
Hers is the strongest single-platform option for Connecticut women. It covers weight loss alongside birth control, hair loss, and mental health, and Connecticut's full insurance parity law means multiple services can be billed to your insurer through one telehealth relationship. Hers holds an 8.8 rating from nearly 30,000 verified reviews. Connecticut's broader Medicaid coverage for women's preventive care through HUSKY Health may also apply to Hers-managed services depending on your specific plan. For women who want weight loss only without multi-condition coverage, Medvi at $149 per month and MyStart Health for a more coached beginner experience are both strong Connecticut options with ratings above 8.5.
How do I qualify for weight loss medication through a Connecticut telehealth provider?
The standard clinical threshold for GLP-1 weight loss medications in Connecticut follows national guidelines: a BMI of 30 or higher qualifies without any additional conditions, and a BMI of 27 or higher qualifies with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Most telehealth platforms serving Connecticut use an online intake form where you enter your height, weight, and health history. A licensed Connecticut provider reviews that intake and determines eligibility. If you qualify clinically, the next step is either a prescription being written directly, or an insurance prior authorization process if you are seeking brand-name Wegovy or Ozempic rather than compounded medication.
What is the difference between Henry Meds and Ro for Connecticut residents seeking Ozempic?
Both Henry Meds and Ro serve Connecticut and both work with insurance on GLP-1 access, but their approaches differ. Henry Meds specializes in diabetes and metabolic health, which means it is experienced at the Ozempic-for-diabetes insurance pathway. If you have type 2 diabetes, Henry Meds may have an easier route to getting Ozempic covered by your Connecticut insurer because the diabetes indication has stronger insurance precedent than the weight loss indication. Ro takes a broader approach, pursuing Wegovy coverage for weight loss patients including those without diabetes, and it offers a compounded semaglutide backup if the brand-name approval fails. Henry Meds holds an 8.6 rating from 12,600 reviews; Ro holds an 8.9 rating from 32,100 reviews.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards